213 related articles for article (PubMed ID: 19837144)
1. In vitro antifungal activity of phenylheptatriyne from Bidens cernua L. against yeasts.
Rybalchenko NP; Prykhodko VA; Nagorna SS; Volynets NN; Ostapchuk AN; Klochko VV; Rybalchenko TV; Avdeeva LV
Fitoterapia; 2010 Jul; 81(5):336-8. PubMed ID: 19837144
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the activity of the preparation cerbiden against Candida spp].
Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
5. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
6. In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
Rukayadi Y; Yong D; Hwang JK
J Antimicrob Chemother; 2006 Jun; 57(6):1231-4. PubMed ID: 16617064
[TBL] [Abstract][Full Text] [Related]
7. [Activity of voriconazole against yeasts isolated from blood culture determined by two methods].
Cantón E; Pemán J; Bosch M; Viudes A; Gobernado M
Rev Esp Quimioter; 2005 Dec; 18(4):308-12. PubMed ID: 16446790
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
10. [Study of the cerbiden spectrum of antifungal activity against fungi pathogenic to humans].
Smirnov VV; Hladun NP; Bondarenko AS; Hahorna SS; Zakharchenko VO
Mikrobiol Z; 2003; 65(3):70-7. PubMed ID: 12945196
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae).
Kosalec I; Pepeljnjak S; Kustrak D
Acta Pharm; 2005 Dec; 55(4):377-85. PubMed ID: 16375827
[TBL] [Abstract][Full Text] [Related]
12. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of antifungal activity of Ononis spinosa L. ash used for the therapy of skin infections as folk remedies].
Altuner EM; Ceter T; Işlek C
Mikrobiyol Bul; 2010 Oct; 44(4):633-9. PubMed ID: 21063975
[TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
Carrillo-Muñoz AJ; Tur-Tur C; Hernández-Molina JM; Quindós G; Marcos-Arias C; Eraso E; Cárdenes D; Ortiz-Maestro O; Santos P; Estivill D; Guardia C; Giusiano G
Rev Esp Quimioter; 2010 Sep; 23(3):122-5. PubMed ID: 20844842
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts].
Ishigaki S; Kawakami S; Ono Y; Miyazawa Y
Kansenshogaku Zasshi; 2000 Mar; 74(3):221-30. PubMed ID: 10783576
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.
Zhang JD; Xu Z; Cao YB; Chen HS; Yan L; An MM; Gao PH; Wang Y; Jia XM; Jiang YY
J Ethnopharmacol; 2006 Jan; 103(1):76-84. PubMed ID: 16169173
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
20. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
Fujita S
Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
